PLOD1 and breast cancer: Aberrant expression of PLOD1 was detected in BC clinical specimens, and inhibition of PLOD1 by siRNA‐mediated knockdown or treatment with a PLOD1 inhibitor significantly reduced the malignant phenotype of BC cells (e.g., decreases in proliferation, migration, and invasion and an increase in apoptosis).